News

Kristine Kucera, PA-C, MPAS, DHS, reflects on her impactful 30-year career and celebrates the evolution of dermatology PAs at the SDPA Fall 2025 conference.

Explore the latest insights on psoriatic arthritis and psoriasis management from Shikha Singla, MD, emphasizing multidisciplinary care and early screening strategies.

SDPA Emerging Scholars share insights on mentorship and professional growth, highlighting the importance of collaboration in dermatology.

At a Case-Based Roundtable event, Cory Rubin, MD, discussed real-world strategies for optimizing systemic therapy in patients with moderate to severe psoriasis.

Catch up on coverage from the first day of the 2025 SDPA Fall Conference held in San Antonio, Texas.

Amanda Mixon, PA-C, highlights critical cutaneous signs of connective tissue diseases at SDPA 2025, enhancing early diagnosis and treatment strategies.

Yasmine Kirkorian, MD, shares insights on pediatric dermatology advancements and genetic skin disorders at SDPA Fall 2025, emphasizing early diagnosis and innovative therapies.

Discover the latest in skin health innovations and skin care trends shared at SDPA Fall 2025, featuring insights from Heather C. Woolery-Lloyd, MD, FAAD.

In a recent Dermatology Times custom video series, Zoe Diana Draelos, MD, and Cheri Frey, MD, discussed evidence-based cleansing and moisturizing practices for sensitive skin.

Marc Serota, MD, discusses using ruxolitinib cream to safely maintain repigmentation, minimize steroid-related adverse effects, and enhance outcomes when combined with phototherapy.

Explore insights from SDPA leaders Renata Block, DMSc, MMS, PA-C, and Sarah Vicari, MMS, PA-C, on mentorship, volunteerism, and fostering growth for PAs.

Findings suggest immune dysregulation and chronic inflammation in atopic dermatitis may contribute to increased skin cancer susceptibility.

ORKA-001 by Oruka Therapeutics offers promising yearly dosing for psoriasis, showcasing extended efficacy and safety in early clinical trials.

What exciting sessions and updates are you looking forward to at the SDPA Fall 2025 Conference in San Antonio? Click here to answer our poll and let us know!

An AI-powered handheld spectroscopy device is showing promise in improving melanoma detection accuracy among primary care physicians, addressing critical gaps in early diagnosis and timely referral.

The FDA issued 18 warning letters to websites illegally selling unapproved and misbranded botulinum toxin products, citing serious safety risks including botulism-related adverse events.

Clinical trials DELTA 1, 2, 3, and DELTA FORCE demonstrated significant improvements in CHE severity and patient-reported outcomes with delgocitinib.

Preview the SDPA Fall 2025 conference in San Antonio for 4 days of networking, education, and expert-led sessions for dermatology PAs.

A phase 2 extension trial found roflumilast foam safe and effective for up to 52 weeks in patients with moderate to severe seborrheic dermatitis.

Skin pain in atopic dermatitis significantly impacts quality of life, necessitating its recognition and treatment as a vital symptom for better patient outcomes.

Explore the latest FDA approvals in dermatology, including treatments for eczema and psoriasis, and gain insights on chronic spontaneous urticaria.

At the 10th Annual Symposium on Hidradenitis Suppurativa Advances, Ralph George, MD, FRCS, emphasized that the growing collaboration between medical and surgical management is redefining the role of procedures in HS.

Allergan Aesthetics pioneers regenerative skincare through secretome science, enhancing skin health with fibroblast-derived exosomes for transformative results.

Lindsay Ackerman, MD, explains the importance of transparency when prescribing medications with boxed warnings.

Incyte launches Ingenuity Awards to empower HS community, funding innovative patient-driven initiatives for better treatment and outcomes in hidradenitis suppurativa.

Castle Biosciences’ new test uses molecular signatures from lesional skin to guide systemic therapy decisions in moderate to severe AD.

Discover how Prithwiraj Maitra, PhD, advances skin care innovation with exosomes, emphasizing scientific validation and ingredient transparency in cosmetic formulations.

From acne to psoriasis, nutrition influences disease severity, treatment response, and patient quality of life.

Explore innovative acne management strategies from James Del Rosso, DO, focusing on personalized treatments and patient education for effective results in diverse cases.

Phio Pharmaceuticals reveals promising results for PH-762, a novel siRNA therapy targeting skin cancer, showcasing effective tumor clearance and safety.